六月 2026
- Home
- Pall
六月 2026的Pall市场份额分析
Pall Corporation, headquartered in Port Washington, New York and a wholly owned subsidiary of Danaher Corporation since 2015, is a global supplier of filtration, separations and purification products. Total revenues for fiscal year 2014 were $2.8 billion, with $103 million spent on R&D.
Pall(包含公司地区分支机构)
查看更多网站流量和参与度信息- pall.com
Pall收入截至 六月 2026为 > 1B
Pall主要域名产生的收入
3 年中Pall主要域名的收入
Pall主要域名的收入
Pall热门域名的总访问量
了解Pall市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Pall热门域名的平均访问时长
分析Pall参与度指标。
过去 3 个月的平均访问时长
子公司明细
Pall热门域名的平均页面浏览量
了解Pall如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Pall 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Brunda left Pall as Global Director Total Rewards, Senior Manager Total Rewards, Senior Human Resources Manager - HR Business Partner on Jul 1st '26.Prior to joining Amagi Corporation, Brunda spent over 13 years with Pall Corporation, where she held several leadership roles including Global Director Total Rewards, Senior Manager Total Rewards, Senior Human Resources Manager - HR Business Partner, and HR Manager.
六月 2, 2026阅读更多
新闻Pall is developing full continuous processing to manufacture monoclonal antibodies on Nov 2nd '17.WuXi Biologics, a Hong Kong-based open-access biologics technology platform company, and its partner Pall Corporation, a provider of advanced filtration, separation, and purification technologies, established a joint laboratory on Nov. 2, 2017 to develop full continuous processing to manufacture monoclonal antibodies (mAbs).
四月 8, 2026阅读更多
新闻G-CON Manufacturing, Inc. partnered with Pall on Sep 26th '18.G-CON Manufacturing and Pall Corporation are collaborating to bring turnkey continuous bioprocess and viral vector production facility solutions to the industry, the companies announced in a Sept. 26, 2018 press release.
四月 8, 2026阅读更多
查看 Pall 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
